Literature DB >> 11934657

The cost of osteoporosis in men: the French situation.

P Levy1, E Levy, M Audran, M Cohen-Solal, P Fardellone, J M Le Parc.   

Abstract

The objective of this study was to estimate the annual direct medical costs of osteoporosis and osteoporotic fractures incurred by French men > or =50 years of age. Costs were assessed from a societal perspective for 1999 and expressed in Euros. An expert panel was consulted to identify fractures attributable to osteoporosis according to International Classification of Diseases (ICD)-10 codes. Available age- and gender-specific osteoporosis attribution probabilities (OAP) were used to derive the proportion of health-care utilization for fractures resulting from osteoporosis. Hospital and ambulatory care costs due to fractures were obtained from French databases. A total of 23,260 acute hospitalizations were found to be caused by osteoporosis, 52% of which are for hip fractures. Mean cost per stay varied widely according to the site of fracture, from 1300 (wrist fracture) to 5900 (hip fracture). Consequently, the total cost of acute hospitalization amounts to 97.6 million, with hip fractures accounting for 73.2% of the expenditures. Rehabilitation and convalescence costs were estimated to be 90.8 million, generating a total hospital cost of 188.4 million. The total outpatient costs were estimated to be 9.1 million. Thus, the total medical costs of male osteoporosis amount to 197.5 million. A sensitivity analysis was performed to test the robustness of this figure. We estimate the number of fractures by applying international incidence rates from the literature to the French male population aged > or =50 years, whereas the OAP and unit costs were kept constant. This approach yielded an estimate of 21,857 fractures, which is only 6% below the base case. When compared with values from other countries, our study results appear very conservative.

Entities:  

Mesh:

Year:  2002        PMID: 11934657     DOI: 10.1016/s8756-3282(01)00708-6

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

1.  Raman and mechanical properties correlate at whole bone- and tissue-levels in a genetic mouse model.

Authors:  Xiaohong Bi; Chetan A Patil; Conor C Lynch; George M Pharr; Anita Mahadevan-Jansen; Jeffry S Nyman
Journal:  J Biomech       Date:  2010-10-28       Impact factor: 2.712

2.  Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database.

Authors:  Milka Maravic; Christine Le Bihan; Paul Landais; Patrice Fardellone
Journal:  Osteoporos Int       Date:  2005-10-11       Impact factor: 4.507

Review 3.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Bone mineral density predicts osteoporotic fractures in elderly men: the MINOS study.

Authors:  Pawel Szulc; Françoise Munoz; François Duboeuf; François Marchand; Pierre D Delmas
Journal:  Osteoporos Int       Date:  2005-08-12       Impact factor: 4.507

5.  Dairy foods and osteoporosis: an example of assessing the health-economic impact of food products.

Authors:  F J B Lötters; I Lenoir-Wijnkoop; P Fardellone; R Rizzoli; E Rocher; M J Poley
Journal:  Osteoporos Int       Date:  2012-06-16       Impact factor: 4.507

6.  Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.

Authors:  Crystal Pike; Howard G Birnbaum; Matt Schiller; Hari Sharma; Russel Burge; Eric T Edgell
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

7.  Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US.

Authors:  C Pike; H G Birnbaum; M Schiller; E Swallow; R T Burge; E T Edgell
Journal:  Osteoporos Int       Date:  2010-05-20       Impact factor: 4.507

8.  Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures.

Authors:  Lucinda Strycker Orsini; Matthew D Rousculp; Stacey R Long; Shaohung Wang
Journal:  Osteoporos Int       Date:  2004-09-01       Impact factor: 4.507

9.  The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis.

Authors:  Hansheng Ding; Nobuo Koinuma; Matt Stevenson; Michiya Ito; Yasutake Monma
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

10.  The hospital resource utilization associated with osteoporotic hip fractures in Kermanshah, Iran.

Authors:  Morteza Saeb; Mandana Beyranvand; Zahra Basiri; Hassan Haghparast-Bidgoli
Journal:  J Inj Violence Res       Date:  2013-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.